{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:42:58Z","timestamp":1780677778803,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T00:00:00Z","timestamp":1484006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s11095-017-2096-4","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T21:41:30Z","timestamp":1484084490000},"page":"696-703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Detection and Specific Elimination of EGFR+ Ovarian Cancer Cells Using a Near Infrared Photoimmunotheranostic Approach"],"prefix":"10.1007","volume":"34","author":[{"given":"Dirk","family":"Bauerschlag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Meinhold-Heerlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bleilevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Br\u00e4utigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wa\u2019el","family":"Al Rawashdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke Maria","family":"Haugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Gremse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Steitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Stickeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Fawzi","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"key":"2096_CR1","first-page":"465","volume":"8","author":"AN Vargas","year":"2014","unstructured":"Vargas AN. Natural history of ovarian cancer. Ecancermedicalscience. 2014;8:465\u201375.","journal-title":"Ecancermedicalscience"},{"key":"2096_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","volume":"10","author":"RL Coleman","year":"2013","unstructured":"Coleman RL, Monk BJ, Sood AK, Herzog TJ. Latest research and clinical treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013;10:211\u201324.","journal-title":"Nat Rev Clin Oncol"},{"key":"2096_CR3","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1200\/JCO.2014.57.4574","volume":"32","author":"KE Oliver","year":"2014","unstructured":"Oliver KE, McGuire WP. Ovarian cancer and antiangiogenic therapy: Caveat Emptor. J Clin Oncol. 2014;32:3353\u20136.","journal-title":"J Clin Oncol"},{"key":"2096_CR4","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","volume":"365","author":"RA Burger","year":"2011","unstructured":"Burger RA, Brady MF, Bookman MA, Fleming GF, Monk BJ, Huang H, et al. Incorporation of Bevacizumab in the primary treatment of ovarian cancer. N Engl J Med. 2011;365:2473\u201383.","journal-title":"N Engl J Med"},{"key":"2096_CR5","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","volume":"365","author":"TJ Perren","year":"2011","unstructured":"Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, et al. A Phase 3 trial of Bevacizumab in ovarian cancer. N Engl J Med. 2011;365:2484\u201396.","journal-title":"N Engl J Med"},{"key":"2096_CR6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177:1053\u201364.","journal-title":"Am J Pathol"},{"key":"2096_CR7","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Bois du","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials. Cancer. 2009;115:1234\u201344.","journal-title":"Cancer"},{"key":"2096_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1535-7163.MCT-14-0658","volume":"14","author":"K Sato","year":"2015","unstructured":"Sato K, Hanaoka H, Watanabe R, Nakajima T, Choyke PL, Kobayashi H. Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer. Mol Cancer Ther. 2015;14:141\u201350.","journal-title":"Mol Cancer Ther"},{"key":"2096_CR9","doi-asserted-by":"crossref","first-page":"E933","DOI":"10.1073\/pnas.1319493111","volume":"111","author":"BQ Spring","year":"2014","unstructured":"Spring BQ, Abu-Yousif AO, Palanisami A, Rizvi I, Zheng X, Mai Z, et al. Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates. Proc Natl Acad Sci U S A. 2014;111:E933\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2096_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chembiol.2013.01.010","volume":"20","author":"P Strop","year":"2013","unstructured":"Strop P, Liu SH, Dorywalska M, Delaria K, Dushin RG, Tran TT, et al. Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates. Chem Biol. 2013;20:161\u20137.","journal-title":"Chem Biol"},{"key":"2096_CR11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/protein\/gzl014","volume":"19","author":"T Gronemeyer","year":"2006","unstructured":"Gronemeyer T, Chidley C, Juillerat A, Heinis C, Johnsson K. Directed evolution of O6-alkylguanine-DNA alkyltransferase for applications in protein labeling. Protein Engineering. Design Select. 2006;19:309\u201316.","journal-title":"Design Select"},{"key":"2096_CR12","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.2174\/1381612811319300014","volume":"19","author":"AF Hussain","year":"2013","unstructured":"Hussain AF, Amoury M, Barth S. SNAP-tag technology: a powerful tool for site specific conjugation of therapeutic and imaging agents. Curr Pharm Des. 2013;19:5437\u201342.","journal-title":"Curr Pharm Des"},{"key":"2096_CR13","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1021\/bc200304k","volume":"22","author":"AF Hussain","year":"2011","unstructured":"Hussain AF, Kampmeier F, von Felbert V, Merk HF, Tur MK, Barth S. SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells. Bioconjug Chem. 2011;22:2487\u201395.","journal-title":"Bioconjug Chem"},{"key":"2096_CR14","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/bm400410e","volume":"14","author":"AF Hussain","year":"2013","unstructured":"Hussain AF, Kruger HR, Kampmeier F, Weissbach T, Licha K, Kratz F, et al. Targeted delivery of dendritic polyglycerol-doxorubicin conjugates by scFv-SNAP fusion protein suppresses EGFR+ cancer cell growth. Biomacromolecules. 2013;14:2510\u201320.","journal-title":"Biomacromolecules"},{"key":"2096_CR15","doi-asserted-by":"crossref","unstructured":"Amoury M, Bauerschlag D, Zeppernick F, von Felbert V, Berges N, Di Fiore S et al. Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand. Oncotarget. 2016; 54925\u201336.","DOI":"10.18632\/oncotarget.10705"},{"key":"2096_CR16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00432-016-2122-7","volume":"142","author":"V Felbert von","year":"2016","unstructured":"von Felbert V, Bauerschlag D, Maass N, Brautigam K, Meinhold-Heerlein I, Woitok M, et al. A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR. J Cancer Res Clin Oncol. 2016;142:1003\u201311.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2096_CR17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1021\/bc200648m","volume":"23","author":"M Mitsunaga","year":"2012","unstructured":"Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjug Chem. 2012;23:604\u20139.","journal-title":"Bioconjug Chem"},{"key":"2096_CR18","doi-asserted-by":"crossref","first-page":"e0157762","DOI":"10.1371\/journal.pone.0157762","volume":"11","author":"S Knutson","year":"2016","unstructured":"Knutson S, Raja E, Bomgarden R, Nlend M, Chen A, Kalyanasundaram R. Development and evaluation of a fluorescent antibody-drug conjugate for molecular imaging and targeted therapy of pancreatic cancer. PLoS One. 2016;11:e0157762.","journal-title":"PLoS One"},{"key":"2096_CR19","first-page":"50","volume":"57","author":"SK Sharma","year":"2016","unstructured":"Sharma SK, Pourat J, Carlin S, Abdel-Atti D, Bankovich A, Sisodiya V, et al. A DLL3-targeted theranostic for small cell lung cancer: Imaging a low density target with a site-specifically modified radioimmunoconjugate. J Nucl Med. 2016;57:50.","journal-title":"J Nucl Med"},{"key":"2096_CR20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/1471-2407-12-345","volume":"12","author":"M Mitsunaga","year":"2012","unstructured":"Mitsunaga M, Nakajima T, Sano K, Kramer-Marek G, Choyke PL, Kobayashi H. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy. BMC Cancer. 2012;12:345.","journal-title":"BMC Cancer"},{"key":"2096_CR21","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","volume":"17","author":"M Mitsunaga","year":"2011","unstructured":"Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med. 2011;17:1685\u201391.","journal-title":"Nat Med"},{"key":"2096_CR22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","volume":"13","author":"E Kipps","year":"2013","unstructured":"Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13:273\u201382.","journal-title":"Nat Rev Cancer"},{"key":"2096_CR23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.2472","volume":"17","author":"GM Dam van","year":"2011","unstructured":"van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 2011;17:1315\u20139.","journal-title":"Nat Med"},{"key":"2096_CR24","doi-asserted-by":"crossref","unstructured":"Tummers QR, Hoogstins CE, Gaarenstroom KN, de Kroon CD, van Poelgeest MI, Vuyk J et al. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17. Oncotarget. 2016: 32144\u201355.","DOI":"10.18632\/oncotarget.8282"},{"key":"2096_CR25","doi-asserted-by":"crossref","first-page":"e0129766","DOI":"10.1371\/journal.pone.0129766","volume":"10","author":"QR Tummers","year":"2015","unstructured":"Tummers QR, Hoogstins CE, Peters AA, de Kroon CD, Trimbos JB, van de Velde CJ, et al. The value of intraoperative near-infrared fluorescence imaging based on enhanced permeability and retention of indocyanine green: feasibility and false-positives in ovarian cancer. PLoS One. 2015;10:e0129766.","journal-title":"PLoS One"},{"key":"2096_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2191-219X-1-31","volume":"1","author":"R Cohen","year":"2011","unstructured":"Cohen R, Stammes MA, de Roos IH, Stigter-van Walsum M, Visser GW, van Dongen GA. Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets. EJNMMI Res. 2011;1:31.","journal-title":"EJNMMI Res"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-017-2096-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T07:51:39Z","timestamp":1498377099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-017-2096-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["2096"],"URL":"https:\/\/doi.org\/10.1007\/s11095-017-2096-4","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,10]]}}}